Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM ... - CNNMoney.com (press release) PDF Print
CNNMoney.com (press release)New onset or worsening renal impairment occurred in patients who received VIBATIV. Renal adverse events were more likely to occur in patients with baseline

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.